Log In
Print
BCIQ
Print
Print this Print this
 

WX-037

  Manage Alerts
Collapse Summary General Information
Company UCB Group
DescriptionPhosphoinositide 3-kinase (PI3K) inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K)
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner

Wilex AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today